Koichi Saruwatari

1.1k total citations
38 papers, 694 citations indexed

About

Koichi Saruwatari is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Koichi Saruwatari has authored 38 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Koichi Saruwatari's work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (13 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Koichi Saruwatari is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (13 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Koichi Saruwatari collaborates with scholars based in Japan, United States and United Kingdom. Koichi Saruwatari's co-authors include Yusuke Tomita, Sho Saeki, Takuro Sakagami, Shinya Sakata, Takayuki Jodai, Shinji Iyama, Kimitaka Akaike, Tokunori Ikeda, Ryo Sato and Shiho Ishizuka and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Koichi Saruwatari

32 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Koichi Saruwatari Japan	12	342	333	212	110	69	38	694
Taiki Hakozaki Japan	14	574 1.7×	330 1.0×	287 1.4×	82 0.7×	55 0.8×	41	810
Zoltán Lohinai Hungary	16	416 1.2×	353 1.1×	273 1.3×	93 0.8×	103 1.5×	40	760
Luis A. Martinez United States	11	423 1.2×	366 1.1×	205 1.0×	172 1.6×	45 0.7×	17	868
Nikolaos Soulitzis Greece	14	265 0.8×	409 1.2×	216 1.0×	141 1.3×	81 1.2×	28	768
Ryo Sato Japan	11	289 0.8×	283 0.8×	115 0.5×	105 1.0×	26 0.4×	22	572
C. Lisanti Italy	9	312 0.9×	321 1.0×	147 0.7×	185 1.7×	50 0.7×	26	679
Semyon A. Risin United States	9	217 0.6×	203 0.6×	99 0.5×	59 0.5×	55 0.8×	25	564
Stephanie J. Gros Germany	16	362 1.1×	272 0.8×	145 0.7×	96 0.9×	44 0.6×	41	698
Hiroyoshi Maeda Japan	13	383 1.1×	273 0.8×	178 0.8×	105 1.0×	84 1.2×	29	695
Tamio Okimoto Japan	15	168 0.5×	210 0.6×	203 1.0×	98 0.9×	84 1.2×	50	643

Countries citing papers authored by Koichi Saruwatari

Since Specialization

Citations

This map shows the geographic impact of Koichi Saruwatari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichi Saruwatari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichi Saruwatari more than expected).

Fields of papers citing papers by Koichi Saruwatari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koichi Saruwatari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichi Saruwatari. The network helps show where Koichi Saruwatari may publish in the future.

Co-authorship network of co-authors of Koichi Saruwatari

This figure shows the co-authorship network connecting the top 25 collaborators of Koichi Saruwatari. A scholar is included among the top collaborators of Koichi Saruwatari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koichi Saruwatari. Koichi Saruwatari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saruwatari, Koichi, et al.. (2025). Selpercatinib-Associated Nephropathy in RET Fusion-Positive Lung Cancer: A Case Successfully Managed With Dose Adjustment and Nephroprotective Therapy. Clinical Lung Cancer. 27(2). 1–5.

Saruwatari, Koichi, Takaaki Tokito, Yoshihiko Sakata, et al.. (2025). Impact of durvalumab re-administration after moderate symptomatic pneumonitis in locally advanced non-small cell lung cancer. Lung Cancer. 204. 108578–108578.

Saruwatari, Koichi, Seitaro Oda, Shinya Shiraishi, et al.. (2024). Negative-predictive value of SUVmax for Ascertaining the efficacy of osimertinib in EGFR mutation-positive non-small cell lung cancer. Respiratory Investigation. 62(6). 1072–1078.

Saruwatari, Koichi, Kosuke Fujino, Takayuki Jodai, et al.. (2024). Negative impact of ratio of the microvascular area to tumor area on the response to EGFR-TKI in non-small cell lung cancer with an EGFR mutation. Journal of Thoracic Disease. 16(2). 1151–1160.

Saruwatari, Koichi, Kenta Murotani, Takaaki Tokito, et al.. (2024). Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients With Unresectable Locally Advanced Nonsmall Cell Lung Cancer: A Multicenter, Retrospective Study. Clinical Lung Cancer. 25(8). 661–671.e7. 2 indexed citations

Tomita, Yusuke, Shinya Sakata, Shinji Iyama, et al.. (2023). Association of Clostridium butyricum Therapy Using the Live Bacterial Product CBM588 with the Survival of Patients with Lung Cancer Receiving Chemoimmunotherapy Combinations. Cancers. 16(1). 47–47. 19 indexed citations

Saruwatari, Koichi, et al.. (2022). Successful treatment with dupilumab for mucus plugs in severe asthma. SHILAP Revista de lepidopterología. 11(1). e01074–e01074. 11 indexed citations

Shiraishi, Yoshimasa, Takayuki Shimose, Hidenobu Ishii, et al.. (2022). Forthcoming Phase II Study of Durvalumab (MEDI4736) Plus Chemotherapy for Small Cell Lung Cancer with Brain Metastases. Cancer Management and Research. Volume 14. 3449–3453. 3 indexed citations

Akaike, Kimitaka, Koichi Saruwatari, Kosuke Fujino, et al.. (2022). Clinical impact of SUVmax of interstitial lesions in lung cancer patients with interstitial lung disease who underwent pulmonary resection. Journal of Thoracic Disease. 14(10). 3801–3810. 2 indexed citations

10.

Sakata, Shinya, Shinji Iyama, Kentaro Tokunaga, et al.. (2021). Airway Pseudomonas aeruginosa density in mechanically ventilated patients: clinical impact and relation to therapeutic efficacy of antibiotics. Critical Care. 25(1). 59–59. 7 indexed citations

11.

Tomita, Yusuke, Tokunori Ikeda, Shinya Sakata, et al.. (2020). Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer. Cancer Immunology Research. 8(10). 1236–1242. 161 indexed citations

12.

Jodai, Takayuki, Koichi Saruwatari, Tokunori Ikeda, et al.. (2020). Clinical outcomes and predictive value of programmed cell death-ligand 1 expression in response to anti-programmed cell death 1/ligand 1 antibodies in non-small cell lung cancer patients with performance status 2 or greater. International Journal of Clinical Oncology. 26(1). 78–86. 4 indexed citations

13.

Saruwatari, Koichi, Tokunori Ikeda, Sho Saeki, et al.. (2019). Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain Metastases. Anticancer Research. 39(2). 923–931. 8 indexed citations

14.

Sakata, Shinya, Sho Saeki, Yoshihiko Sakata, et al.. (2018). The impact of continuing ALK inhibitors beyond initial disease progression on clinical outcome in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter retrospective analysis. Annals of Oncology. 29. ix163–ix163. 1 indexed citations

15.

Akaike, Kimitaka, Koichi Saruwatari, Hiroko Okabayashi, et al.. (2018). Negative Impact of Coexisting Interstitial Lung Disease on Clinical Outcomes in Small-cell Lung Cancer Patients. Anticancer Research. 38(11). 6543–6550. 3 indexed citations

16.

Ichikawa, Tomohiro, Koichi Saruwatari, Sachiyo Mimaki, et al.. (2017). Immunohistochemical and genetic characteristics of lung cancer mimicking organizing pneumonia. Lung Cancer. 113. 134–139. 4 indexed citations

17.

Goto, Masaki, Masahito Naito, Koichi Saruwatari, et al.. (2016). The ratio of cancer cells to stroma after induction therapy in the treatment of non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 143(2). 215–223. 5 indexed citations

18.

Makinoshima, Hideki, Masahiro Takita, Koichi Saruwatari, et al.. (2015). Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma. Journal of Biological Chemistry. 290(28). 17495–17504. 153 indexed citations

19.

Saruwatari, Koichi, Shinnosuke Ikemura, Keigo Sekihara, et al.. (2015). Aggressive tumor microenvironment of solid predominant lung adenocarcinoma subtype harboring with epidermal growth factor receptor mutations. Lung Cancer. 91. 7–14. 32 indexed citations

20.

Sekihara, Keigo, Tomoyuki Hishida, Shinnosuke Ikemura, et al.. (2015). The association of intravascular stromal cells with prognosis in high-grade neuroendocrine carcinoma of the lung. Journal of Cancer Research and Clinical Oncology. 142(5). 905–912. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact